Breaking: FDA approves pill version of Wegovy

Novo did not immediately release details on pricing

Log In    Subscribe BREAKING NEWS   FDA approves pill version of Novo Nordisk's Wegovy, possibly widening access By Elaine Chen Sergei Gapon/AFP via Getty Images The FDA has approved the oral version of Novo Nordisk's injectable weight loss drug Wegovy, making it the first GLP-1 pill to be cleared by regulators for obesity and possibly allowing many more Americans to get access to a highly effective treatment. READ MORE Sign up for Biotech Scorecard Unfiltered, uncompromising analysis on the biotech world. Learn more. In Case You Missed It 3 key issues to watch at FDA as Makary struggles to stabilize the agency By Lizzy Lawrence What Ozempic might tell us about the future of Alzheimer's By Jason Karlawish Exclusive: FDA voucher program has become vehicle for political interference in drug review decisions, staffers say By Lizzy Lawrence The Worst Biopharma CEO of 2025 made decisions with tragic consequences By Adam Feuerstein Don't miss out on another STAT Investigation Unlock the world of health and medicine with a subscription to STAT+ Learn more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us